| GO:0001666 |
P |
response to hypoxia |
| GO:0005506 |
F |
iron ion binding |
| GO:0005515 |
F |
protein binding |
| GO:0005634 |
C |
nucleus |
| GO:0005737 |
C |
cytoplasm |
| GO:0005829 |
C |
cytosol |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0016705 |
F |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0016706 |
F |
2-oxoglutarate-dependent dioxygenase activity |
| GO:0018401 |
P |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline |
| GO:0019899 |
F |
enzyme binding |
| GO:0030821 |
P |
obsolete negative regulation of cAMP catabolic process |
| GO:0031418 |
F |
L-ascorbic acid binding |
| GO:0031543 |
F |
peptidyl-proline dioxygenase activity |
| GO:0031545 |
F |
peptidyl-proline 4-dioxygenase activity |
| GO:0032364 |
P |
oxygen homeostasis |
| GO:0043433 |
P |
negative regulation of DNA-binding transcription factor activity |
| GO:0045765 |
P |
regulation of angiogenesis |
| GO:0046872 |
F |
metal ion binding |
| GO:0051213 |
F |
dioxygenase activity |
| GO:0051344 |
P |
negative regulation of cyclic-nucleotide phosphodiesterase activity |
| GO:0055008 |
P |
cardiac muscle tissue morphogenesis |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
| GO:0060347 |
P |
heart trabecula formation |
| GO:0060412 |
P |
ventricular septum morphogenesis |
| GO:0060711 |
P |
labyrinthine layer development |
| GO:0061418 |
P |
regulation of transcription from RNA polymerase II promoter in response to hypoxia |
| GO:0071731 |
P |
response to nitric oxide |